Literature DB >> 30302663

Long-term sequelae of the less than total thyroidectomy procedures for benign thyroid nodular disease.

Georgios Boutzios1, Gerasimos Tsourouflis2, Zoe Garoufalia2, Krystallenia Alexandraki3, Grigorios Kouraklis2.   

Abstract

INTRODUCTION: Nodular goiter is the most common disorder of the thyroid gland. Less than total thyroidectomy procedures are considered the gold standard in the surgical management of nodular thyroid disease despite its propensity for recurrence. The aim of the study was to assess long-term sequelae of the less than total thyroidectomy procedures.
MATERIAL AND METHODS: In this single-center retrospective study, records of 154 patients that underwent less than total thyroidectomy, for nodular disease and/or hyperthyroidism between 1998 and 2013, were reviewed. Patients with malignant findings in the histology report and a follow-up of less than 5 years were excluded.
RESULTS: The mean age of the recorded patients was 65.1 ± 12.91 years of which 132 were females. Subtotal thyroidectomy was performed in 45.5% of the study population, 22.1% underwent partial thyroidectomy, while the remaining 32.5% underwent lobectomy. Long-term thyroxine supplementation was administered in 138 patients (89.6%). Recurrence of clinically important nodules (>1 cm) was observed in 68.2% of patients but only 11% of the population underwent completion thyroidectomy. In the univariate analysis, the duration of follow-up (p = 0.00005, C.I.: 0.903-0.965) as well as the type of operation (p = 0.035, C.I.: 1.031-2.348) appeared to have a significant correlation with nodular recurrence. The multivariate analysis identified the duration of follow-up (p = 0.0005, C.I.: 0.908-0.973) as the only significant predictive factor of nodular recurrence.
CONCLUSION: This is the first study with such a long duration of post-operative follow-up. The high rate of nodular recurrence in less than total thyroidectomy procedures along with the lifelong need for thyroxine supplementation suggest that a more conservative surgical approach is needed. When surgery is recommended, we suggest total thyroidectomy as the treatment of choice to avoid the recurrence of disease, the high cost associated with frequent follow-ups by means of sonography as well as thyroxine replacement therapy.

Entities:  

Keywords:  Nodular recurrence; Thyroid lobectomy; Thyroid nodules

Mesh:

Substances:

Year:  2018        PMID: 30302663     DOI: 10.1007/s12020-018-1778-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  27 in total

1.  High rate of recurrence after lobectomy for solitary thyroid nodule.

Authors:  Maunzio Marchesi; Marco Biffoni; Cristiana Faloci; Fausto Biancari; Francesco P Campana
Journal:  Eur J Surg       Date:  2002

2.  Predictive factors for recurrence after thyroid lobectomy for unilateral non-toxic goiter in an endemic area: results of a multivariate analysis.

Authors:  Rocco Bellantone; Celestino Pio Lombardi; Mauro Boscherini; Marco Raffaelli; Vincenzo Tondolo; Pier Francesco Alesina; Salvatore Maria Corsello; Danilo Fintini; Maurizio Bossola
Journal:  Surgery       Date:  2004-12       Impact factor: 3.982

3.  Long-term follow-up of contralateral lobe in patients hemithyroidectomized for solitary follicular adenoma.

Authors:  H Niepomniszcze; A Garcia; E Faure; A Castellanos; M del Carmen Zalazar; G Bur; B Elsner
Journal:  Clin Endocrinol (Oxf)       Date:  2001-10       Impact factor: 3.478

4.  What constitutes adequate surgical therapy for benign nodular goiter?

Authors:  Roy Phitayakorn; Divya Narendra; Sarah Bell; Christopher R McHenry
Journal:  J Surg Res       Date:  2008-06-02       Impact factor: 2.192

5.  Symptomatic benign multinodular goiter: unilateral or bilateral thyroidectomy?

Authors:  Sarah E Olson; James Starling; Herbert Chen
Journal:  Surgery       Date:  2007-10       Impact factor: 3.982

6.  Thyroid hormone replacement after thyroid lobectomy.

Authors:  Samantha J Stoll; Susan C Pitt; Jing Liu; Sarah Schaefer; Rebecca S Sippel; Herbert Chen
Journal:  Surgery       Date:  2009-10       Impact factor: 3.982

7.  Does unilateral lobectomy suffice to manage unilateral nontoxic goiter?

Authors:  Gurkan Yetkin; Mehmet Uludag; Ozgun Onceken; Bulent Citgez; Adnan Isgor; Ismail Akgun
Journal:  Endocr Pract       Date:  2010 Jan-Feb       Impact factor: 3.443

8.  [Benign diseases of the thyroid: indications for surgical treatment and the current role of total thyroidectomy].

Authors:  Luigi Sandonato; Giuseppa Graceffa; Calogero Cipolla; Salvatore Fricano; Paola Acquaro; Federica Latteri; Mario Adelfio Latteri
Journal:  Chir Ital       Date:  2003 Mar-Apr

Review 9.  Is total thyroidectomy the surgical procedure of choice for benign multinodular goiter? An evidence-based review.

Authors:  Gaurav Agarwal; Vivek Aggarwal
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

Review 10.  Treatment and prevention of recurrence of multinodular goiter: an evidence-based review of the literature.

Authors:  Jacob Moalem; Insoo Suh; Quan-Yang Duh
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

View more
  1 in total

1.  Patient satisfaction following thyroidectomy in surgical mission: a prospective study.

Authors:  Mahir Gachabayov; Rifat Latifi
Journal:  Gland Surg       Date:  2019-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.